ISDA

Entry Detail

PDB ID:

4NB6

Keywords:

TRANSCRIPTION

Title:

Crystal structure of the ligand binding domain of RORC with T0901317

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2013-10-22

Release Date:

2013-11-27

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.85 Å

R-Value Free:

0.27

R-Value Work:

0.21

R-Value Observed:

0.22

Space Group:

P 61

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Nuclear receptor ROR-gamma
Chain IDs:A, B
Chain Length:251
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P51449 Pfam ID:PF00104

Ligand Molecules

444

Primary Citation

Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc.

Fauber, B.P, de Leon Boenig, G, Burton, B, Eidenschenk, C, Everett, C, Gobbi, A, Hymowitz, S.G, Johnson, A.R, Liimatta, M, Lockey, P, Norman, M, Ouyang, W, Rene, O, Wong, H.Show

Bioorg.Med.Chem.Lett. 23 6604 6609 (2013)

PMID: 24239186 DOI: 10.1016/j.bmcl.2013.10.054

Abstact

The structure-activity relationships of T0901317 analogs were explored as RORc inverse agonists using the principles of property- and structure-based drug design. An X-ray co-crystal structure of T0901317 and RORc was obtained and provided molecular insight into why T0901317 functioned as an inverse agonist of RORc; whereas, the same ligand functioned as an agonist of FXR, LXR, and PXR. The structural data was also used to design inhibitors with improved RORc biochemical and cellular activities. The improved inhibitors possessed enhanced selectivity profiles (rationalized using the X-ray crystallographic data) against other nuclear receptors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures